2Charlaps, Lichstein E, William H, et al. Adrenergine blocking drugs in the treatment of congestive heart failure. Med Cli North American, 1989,73 (2) : 373.
2The digitalis investigation group. The effects of digoxin on mortality and morbidity in patients with heart failure[J] . N Engl J Med,1997, 336(8) :525-533.
3Helber I, Santos AA, Bocalini D, et al. Digitoxin pro- longs survival of female rats with heart failure due to large myocardial infarction[J]. J Card Fail, 2009, 15 (9) :798-804.
4Santos AA, Helber I, Flumignan RLC, et al. Doppler echocardiographic predictors of mortality in female rats after myocardial infarction[J]. J Card Fail, 2009, 15 (2) :163-168.
5dos Santos L, Antonio EL, Tucci PJF, et al. Determi- nation of myocardial infarction size in rats by echocar- diogrphy and tetrazolium staining: correlation, agree- ments, and simplification[J]. Braz J Med Biol Res, 2008, 41(3) ..199-201.
6Kanashiro RM, Nozawa E, Murad N, et al. Myocardi- al infarction scar plication in the rat.- cardiac mechanics in an animal model for surgical procedures[J]. Ann Thorac Surg, 2002, 73(5):1 507-1 513.
7Portes LA, Saraiva RM, Santos AA, et al. Swimming training attenuates remodeling, contratile dysfunction and congestive heart failure in rats with moderate and large myocardial infarction [J]. Clin Exp Pharmacol Physiol, 2009,36(4) :394-399.
8Ahmed A, Rich MW, Love TE, et al. Digoxin and re- duction in mortality and hospitalization in heart failure: a comprehensive post hoe analysis of the DIG trial[J]. Eur Heart J,2006, 27(2) :178-186.
9Rathore SS Curtis JP Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure[J]. JAMA ,200a, 289(7)871-878.
